Table 2.
Neuropathology of Mendelian genetic forms of Parkinson’s disease
Locus/gene | Mutation | Neuropathology | References |
---|---|---|---|
PARK1,4/SNCA | p.A53T, p.A30P, p.E46 K | Nigral neuronal loss, cortical and brainstem Lewy bodies | [22, 35, 121, 136] |
SNCA triplication/duplication | Cortical and brainstem Lewy bodies, temporal lobe vacuolation. | [25, 84, 90] | |
PARK2/PARKIN | Exon4Del/Exon4Del p.K211 N/Exon4Del p.Q34fs/p.Q34fs |
Nigral neuronal loss, no Lewy bodies | [37, 43, 83, 128] |
Exon3Del/Exon3Del | Nigral neuronal loss, no Lewy bodies, α-synuclein positive inclusions in the pedunculopontine nucleus | [108] | |
p.R275W/p.Pro113fsX51 | Cortical Lewy bodies, none in the brainstem but occasional Lewy neurites in the dorsal nucleus of vagus. | [24] | |
Del1072T/Exon7Del | Lewy bodies in the locus ceruleus and substantia nigra | [103] | |
PARK8/LRRK2 | p.G2019S | Neuropathology ranges from non-specific nigral degeneration to widespread Lewy body disease. | [30, 32, 58, 106] |
p.R1441C | Varies from Lewy body disease to nigral degeneration with ubiquitin positive inclusions to severe tau pathology | [139] | |
p.R1441G/p.I2020T | Non-specific nigral degeneration | [27, 77] | |
p.Y1699C | Varies from Lewy body disease to nigral degeneration with ubiquitin positive inclusions or Alzheimer pathology | [58, 139] | |
PARK6/PINK1 | Exon7Del/c.1488 + 1G > A | Nigral neuronal loss, Lewy bodies and aberrant neurites in the reticular nuclei of the brainstem, substantia nigra pars compacta and Meynert nucleus. | [107] |
PARK14/ PLA2G6 |
p.R37X/c.1078–3C>A p.T572I/p.T572I | Range from mild to severe Lewy body disease, with neurofibrillary tangles and axonal speroids | [94] |
PANK2 | p.G521R/p.G521R | No Lewy bodies, diffuse tau pathology | [60] |
Neuropathology is grouped according to mutation